Edition:
India

Iovance Biotherapeutics Inc (IOVA.OQ)

IOVA.OQ on NASDAQ Stock Exchange Global Market

13.60USD
20 Jun 2018
Change (% chg)

-- (--)
Prev Close
$13.60
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
235,460
52-wk High
$19.80
52-wk Low
$4.45

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Mar '18 0.00 -0.314
FY 2017 Dec '17 0.00 -0.355
Sep '17 0.00 -0.350
Jun '17 0.00 -0.374
Mar '17 0.00 -0.332
FY 2016 Dec '16 0.00 -0.252
Sep '16 0.00 -1.154
Jun '16 0.00 -0.226
Mar '16 0.00 -0.142
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-18 4 0.00 0.00 0.00 0.00
Quarter Ending Sep-18 4 0.00 0.00 0.00 0.00
Year Ending Dec-18 5 0.00 0.00 0.00 0.00
Year Ending Dec-19 6 0.00 0.00 0.00 10.00
Earnings (per share)
Quarter Ending Jun-18 6 -0.31 -0.29 -0.34 -0.32
Quarter Ending Sep-18 6 -0.32 -0.29 -0.35 -0.33
Year Ending Dec-18 6 -1.26 -1.17 -1.36 -1.38
Year Ending Dec-19 7 -1.38 -1.25 -1.52 -1.38
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

Dividends

Growth Rates

Financial Strength

Profitability Ratios

Efficiency

Management Effectiveness

  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -197.33 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Iovance Biotherapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 7.53 3.83 99 --
13 Week 15.44 9.82 99 --
26 Week 19.85 10.74 99 --
52 Week 1.29 -14.15 99 --
YTD 12.95 -0.81 99 --
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 93.23%
# of Holders: 180
Total Shares Held: 83,575,364
3 Mo. Net Change: 20,225,545
# New Positions: 46
# Closed Positions: 10
# Increased Positions: 116
# Reduced Positions: 39
# Net Buyers: 77
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.